The Medicines Company

MDCO

US5846881051

Pharmaceuticals

Delayed Nasdaq Other stock markets			5-day change	1st Jan Change
- ^USD	-.--%		+0.14%	-0.05%

2020	The Medicines Company Announces Board Changes	CI
2020	The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care	CI

The Medicines Company Announces Resignation of Fredric N. Eshelman

August 28, 2018 at 09:56 pm

On August 23, 2018, Fredric N. Eshelman notified The Medicines Company of his decision to resign from the Board of Directors of the company effective as of August 24, 2018.

Latest news about The Medicines Company

The Medicines Company Announces Board Changes	06/01/20	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care	06/01/20	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P TMI Index	06/01/20	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P 1000	06/01/20	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P Global BMI Index	06/01/20	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P Composite 1500	06/01/20	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600	06/01/20	CI
The Medicines Company(NasdaqGS:MDCO) dropped from S&P Biotechnology Select Industry Index	06/01/20	CI
The Medicines Company(NasdaqGS:MDCO) dropped from NASDAQ Biotechnology Index	06/01/20	CI
The Medicines Company(NasdaqGS:MDCO) dropped from NASDAQ Composite Index	06/01/20	CI
Novartis AG completed the acquisition of The Medicines Company.	02/01/20	CI
World share markets rally on revived trade hopes; dollar gains	25/11/19	RE
World share markets rally on revived trade hopes; dollar gains	25/11/19	RE
Transatlantic dealmaking sends European shares back to four-year peak	25/11/19	RE
Black Friday frenzy: Tiffany buys LVMH, Charles Schwab buys TD Ameritrade, Novartis buys Medicines Company…	25/11/19
Novartis takes on Sanofi, Amgen with $9.7 billion takeover of heart drug maker	25/11/19	RE
Transcript : Novartis AG, The Medicines Company - M&A Call	25/11/19
Novartis AG entered into definitive agreement to acquire The Medicines Company for $6.8 billion.	23/11/19	CI
Ionis Pharmaceuticals : Novartis nears deal to buy U.S. biotech firm Medicines Co for about $7 billion - WSJ	23/11/19	RE
Novartis Reportedly Holds Talks to Acquire Medicines Co	19/11/19	CI
Medicines : Novartis eyes Medicines Co to boost cardio franchise - report	19/11/19	RE
Transcript : The Medicines Company - Special Call	18/11/19
The Medicines Company Announces ORION-10 Study of Inclisiran in ASCVD Patients Showed Durable and Potent Lowering of LDL-C with Twice-Yearly Dosing	16/11/19	CI
The Medicines Company Announces Detailed Results from the ORION-9 and ORION-10 Pivotal Phase 3 Clinical Studies of Inclisiran	06/11/19	CI
Transcript : The Medicines Company, Q3 2019 Earnings Call, Oct 30, 2019	30/10/19

The Medicines Company is a global biopharmaceutical company. The Company is focused on the development of inclisiran, a twice-yearly therapy that allows administration during patients routine visits to their healthcare professionals and potentially contributes to improved patient adherence and sustained lower LDL-C levels. The Company is a subsidiary of Novartis AG.

Sector

Pharmaceuticals

More about the company

Sector Generic Pharmaceuticals

	1st Jan change	Capi.
THE MEDICINES COMPANY	-0.05%	6.79B
SUN PHARMACEUTICAL INDUSTRIES LTD.	+18.04%	42.95B
OTSUKA HOLDINGS CO., LTD.	+16.92%	21.38B
SANDOZ GROUP AG	+18.33%	15.05B
CIPLA LIMITED	+19.27%	14.45B
ZYDUS LIFESCIENCES LIMITED	+56.12%	13.04B
ONO PHARMACEUTICAL CO., LTD.	-10.73%	6.72B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+11.21%	5.47B
RICHTER GEDEON VEGYÉSZETI GYÁR NYILVÁNOSAN MUKÖDO RT.	+7.31%	4.84B

Generic Pharmaceuticals